Arcoma AB - Asset Resilience Ratio

Latest as of March 2016: 18.92%

Arcoma AB (ARCOMA) has an Asset Resilience Ratio of 18.92% as of March 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Arcoma AB carry for a breakdown of total debt and financial obligations.

Liquid Assets

Skr14.41 Million
≈ $1.55 Million USD Cash + Short-term Investments

Total Assets

Skr76.19 Million
≈ $8.20 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Arcoma AB's Asset Resilience Ratio has changed over time. See Arcoma AB (ARCOMA) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Arcoma AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ARCOMA market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr14.41 Million 18.92%
Total Liquid Assets Skr14.41 Million 18.92%

Asset Resilience Insights

  • Good Liquidity Position: Arcoma AB maintains a healthy 18.92% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Arcoma AB Industry Peers by Asset Resilience Ratio

Compare Arcoma AB's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
INKON Life Technology Co Ltd
SHE:300143
Medical Devices 3.37%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
Medical Devices 54.67%
Universus Photo Imagings Limited
NSE:UNIVPHOTO
Medical Devices 30.97%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%
Aligned Genetics Inc
KQ:238120
Medical Devices 2.22%
Heramed Ltd
AU:HMD
Medical Devices 0.83%
Acarix A/S
ST:ACARIX
Medical Devices 37.81%

Annual Asset Resilience Ratio for Arcoma AB (None–None)

The table below shows the annual Asset Resilience Ratio data for Arcoma AB.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points

About Arcoma AB

ST:ARCOMA Sweden Medical Devices
Market Cap
$11.55 Million
Skr107.31 Million SEK
Market Cap Rank
#26507 Global
#571 in Sweden
Share Price
Skr7.50
Change (1 day)
+0.00%
52-Week Range
Skr6.92 - Skr10.75
All Time High
Skr25.60
About

Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more